Check Your Claims Before Reviewers Do

 Quick Explanation Copied

 Long Explanation

Profile and Citation Impact

Linda Vignozzi, affiliated with the University of Florence and Società Italiana di Endocrinologia, has 563 indexed works, 16,328 total citations, and an h-index of 73 — placing her among the most-cited investigators in andrology and sexual medicine OpenAlex bibliometric profile for Linda Vignozzi. Her annual citation impact peaked around 2012 (1,840 citations) and remained above 1,000/year through 2014, 2019, and 2020–2021, with a natural lag effect in recent years (2024–2026).

Key Contributions

Her most influential works include the validation of the 6-item Female Sexual Function Index (FSFI-6) as a rapid screening tool for female sexual dysfunction — a methodological benchmark cited ~364 times FSFI-6 validation study, J Sex Med 2009; preclinical demonstration that androgens regulate PDE5 expression and functional activity in corpora cavernosa (~336 citations) Androgen-PDE5 regulation study, Endocrinology 2004; and meta-analyses on PDE5 inhibitors for LUTS/BPH (~330 citations) PDE5i for BPH meta-analysis, Eur Urol 2012. She also contributed to major consensus and guideline documents, including the Global Consensus Position Statement on testosterone therapy for women (~279 citations) Global consensus on testosterone for women, JCEM 2019, the ISSWSH process of care for HSDD in women ISSWSH HSDD care process, Mayo Clin Proc 2018, and SIE consensus on very-low-calorie ketogenic diets SIE VLCKD consensus statement, J Endocrinol Invest 2019.

Critical Assessment and Limitations

Strengths: The citation trajectory shows sustained, decade-spanning influence; the h-index of 73 with 563 works indicates both productivity and durable impact. She bridges bench science (PDE5 biochemistry) with clinical instrument development (FSFI-6) and high-level guidelines — a hallmark of translational maturity. Weaknesses and caveats: In her top-cited works she is predominantly a middle author, suggesting a network-driven citation profile centered on the Florence andrology group (Maggi, Corona, Gacci) rather than first-authored paradigm shifts. OpenAlex also fragments her name into at least five entity profiles, so the merged metrics may include some small disambiguation noise (or, conversely, the smaller profiles with h-index 0–1 suggest some true disambiguation loss). The 2020 testosterone–COVID prognostic study Testosterone and COVID-19 outcomes, Andrology 2020 is observational and association-based; causality is not established and confounding (age, metabolic disease) cannot be excluded from the abstract alone. Note: BGPT did not receive full publication lists, so this review reflects only the top-10 most-cited works; first-authorship rate, retractions, and funding disclosures are unknown.

 BGPT Author Review

Scientific Quality

H-index of 73 with 563 works and ~16,300 citations places Vignozzi in the upper tier of sexual medicine and endocrinology researchers. She has made durable contributions across preclinical andrology (PDE5-androgen regulation), clinical instrument validation (FSFI-6), meta-analyses, and international consensus statements. The main deductive caution: her most-cited papers position her as a middle author within a strong Florentine group, so individual scientific leadership is harder to isolate. Score reflects strong, sustained, translational output rather than singular first-authored breakthroughs.

Communication Quality

Top works include validated clinical questionnaires, meta-analyses, and consensus statements — formats that demand and demonstrate clear structured communication. However, no direct evidence of her individual writing style, patient-facing communication, or pedagogical output was available; score is inferred from document types and guideline authorship.

Author Novelty

Her work spans genuinely novel preclinical findings (androgen regulation of PDE5 in corporal tissue, 2004) and practical innovation (FSFI-6 rapid screener), but much recent output is guideline consolidation, meta-analysis, and incremental clinical epidemiology. Solid scientific novelty at the field's applied frontier rather than paradigm-shifting originality.

Scientific Rigor

Evidence of methodological rigor: validation studies with defined psychometric aims, systematic reviews with meta-analysis, and consensus statements with extensive reference bases (up to 212 references). The COVID-testosterone prognostic work is observational and thus inherently more vulnerable to confounding. No retraction or misconduct signals appear in the supplied data, but full methodology review was not possible.